Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy

Parkinson's disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases representative of α-synucleinopathies characterized pathologically by α-synuclein-abundant Lewy bodies and glial cytoplasmic inclusions, respectively. Embryonic stem cells, fetal mesencephalic neurons, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Phil Hyu, Park, Hyun Jung
Formato: Texto
Lenguaje:English
Publicado: Korean Neurological Association 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686892/
https://www.ncbi.nlm.nih.gov/pubmed/19513327
http://dx.doi.org/10.3988/jcn.2009.5.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686892/
https://www.ncbi.nlm.nih.gov/pubmed/19513327
http://dx.doi.org/10.3988/jcn.2009.5.1.1

Ejemplares similares